First LSD-Based Drug Receives FDA Breakthrough Designation, Paving the Way for New Innovation

· Business · By ReportWire
First LSD-Based Drug Receives FDA Breakthrough Designation, Paving the Way for New Innovation

The FDA has given MindMed’s LSD-based drug breakthrough-therapy status, paving the way for more innovation and investment in the space.

Chloe Aiello

Source link